Rating : 10/10 (⭐⭐⭐⭐⭐)
🔹Professor Dr. Stefan Dresel his outstanding contributions and accomplishments in his field. His illustrious career is characterized by a remarkable blend of academic achievements, clinical expertise, and innovative research endeavors. Between 1984 and 1991, there was a dedicated pursuit of human medicine, with each year bringing new knowledge and expertise in the field of medicine.
🔹In 1993, a significant milestone was reached with the attainment of a doctorate from Ludwig Maximilians University in München, merging academic pursuit with practical knowledge. From 1992 to 1994, the role of a research assistant at Ludwig-Maximilians-Universität München's radiological clinic provided an opportunity for growth and discovery in the world of research. In 1994, there was a shift to the Clinic and Polyclinic for Nuclear Medicine as a Research Assistant, where the field of nuclear medicine became a new frontier to explore.
🔹In 1995, research continued at the Institute of Radiological Diagnostics at Ludwig-Maximilians-Universität München, with a focus on Magnetic Resonance Imaging under the guidance of Prof. Dr. K. Hahn. In 1996, the role of a Senior Physician was embraced within the Nuclear Medicine Clinic and Polyclinic at Ludwig-Maximilians-Universität München, where healing and expertise converged. Also in 1996, a significant milestone was achieved with certification as a Nuclear Medicine Specialist, demonstrating dedication to specialization and mastery.
🔹From 1996 to 1998, the journey extended to the Radiology Department at the University of Pennsylvania in Philadelphia, USA, as a Research Fellow, offering a cross-continental exploration of the field. In 2001, a notable achievement was earned: the attainment of Habilitation, a teaching authorization in Nuclear Medicine, showcasing expertise and academic prowess. From 1998 to 2004, the role of Senior Physician within the clinic and nuclear medicine polyclinic at Ludwig-Maximilians-Universität München marked a period of leadership and growth.
🔹A significant chapter unfolded in 2004 when the role of Chief Physician at Robert-Rössle-Klinik's Department of Nuclear Medicine was assumed, marking a pivotal step towards leadership and innovation. The journey culminated in the present, where the role of Chief Physician and Director of Nuclear Medicine at Helios Klinikum Berlin-Buch has been embraced since 2007. This represents a realm of exceptional healing and leadership that has been meticulously cultivated. In this journey of expertise and growth, each year represents a chapter of dedication and mastery, showcasing an unwavering commitment to the field of nuclear medicine and the relentless pursuit of excellence.
EDUCATION:
🔹1984-1991: Medical studies at Ludwig Maximilian University of Munich.
🔹1993: Doctorate (Ph.D.).
PROFESSIONAL JOURNEY:
🔹1992-1994: Research Assistant, Radiological Clinic, LMU Munich.
🔹1994-1995: Research Assistant, Clinic and Polyclinic for Nuclear Medicine, LMU Munich, Großhadern.
🔹1995: Research Assistant, Institute for Radiological Diagnostics, Magnetic Resonance Imaging, LMU Munich (Acting Director: Prof. Dr. K. Hahn).
🔹1996: Senior Physician, Clinic and Polyclinic for Nuclear Medicine, LMU Munich, Innenstadt.
🔹1996: Recognition as a Specialist in Nuclear Medicine.
🔹1996-1998: Research Fellow, Department of Radiology, University of Pennsylvania, Philadelphia, USA.
🔹1998-2004: Senior Physician, Clinic and Polyclinic for Nuclear Medicine, LMU Munich, Innenstadt.
🔹2001: Habilitation, granting of teaching authorization in the field of Nuclear Medicine.
🔹Since 2004: Chief Physician of the Nuclear Medicine Clinic, HELIOS Klinikum Berlin, and Head of the Nuclear Medicine Functional Area at Robert-Rössle-Klinik, HELIOS Klinikum Berlin.
🔹Since 2007: Extraordinary Professor at LMU Munich.
🔹Since 2008: Specialist Group Leader in Radiology/Radiotherapy/Nuclear Medicine.
🔹Diagnosis and treatment of benign and malignant thyroid diseases treatment in Germany.
🔹 PET/CT diagnostics with F-18 FDG, Ga-68 PSMA, and Ga-68 Dotatoc treatment in Germany.
🔹Radioreceptor therapy for neuroendocrine tumors with Lu-177 Dotatoc treatment in Germany.
🔹Therapy for metastatic prostate cancer with Lu-177 PSMA treatment in Germany.
🔹Therapy for liver tumors and liver metastases using Selective Internal Radiotherapy (SIRT) treatment in Germany.